GMAB Competitors & Alternatives
Compare Genmab AS with similar stocks in the same industry
Biotechnology
GMAB
Main Stock$33.02
Tradestie Score
35
Market Cap
$19.56B
P/E Ratio
26.3
Revenue Growth
0.2%
Analyst Upside
+17.6%
Top Competitors
238 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
BNTX
BioNTech SE American Depositary Share
|
$112.82
|
$24.57B | - | 29 | Compare |
|
INCY
Incyte Genomics Inc
|
$127.98
|
$16.93B | 16.3 | 45 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$61.33
|
$15.70B | 32.6 | 40 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$12.73
|
$15.22B | - | 46 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$251.95
|
$12.36B | 19.4 | 50 | Compare |
|
EXEL
Exelixis Inc
|
$54.55
|
$11.09B | 17.0 | 51 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$36.36
|
$10.76B | - | 45 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$138.89
|
$10.74B | - | 36 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$65.07
|
$10.53B | 180.3 | 39 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$62.04
|
$10.49B | - | 37 | Compare |
More GMAB Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2834)
238 stocks in this industry